Definition of metabolic syndrome: Tower of Babel;Definición de síndrome metabólico: La Torre de Babel

Archivos de Cardiologia de Mexico

Volumn 75, Issue 2, 2005, Pages 230-233

  Rosas Peralta, Martin ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TUMOR NECROSIS FACTOR;

DIABETES MELLITUS; HEART MUSCLE METABOLISM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; METABOLIC SYNDROME X; NOTE; OBESITY;

HUMANS; METABOLIC SYNDROME X;

EID: 24144464014     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (12)

1. VELÁZQUEZ MONROY O, ROSAS PERALTA M, LARA ESQUEDA A, PASTELÍN HERNANDEZ G, ATTIE F, TAPIA CONYER R: Hipertensión Arterial en México: Resultados de la encuesta nacional de salud 2000. Arch Cardiol Mex 2002; 72: 71-84.
2. VELÁZQUEZ MONROY O, ROSAS PERALTA M, LARA ESQUEDA A, PASTELÍN HERNÁNDEZ G, ATTIE F, TAPIA CONYER R: Prevalencia e Interrelación de Enfermedades Crónicas No Trasmisibles y Factores de riesgo Cardiovascular en México. Resultados Finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2003; 73: 62-77.
3. LARA EA, ROSAS PM, ET AL: Hipercolesterolemia e Hipertensión en México. Arch Cardiol Mex 2004; 74: 231-245.
4. REAVEN GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
5. PYORALA K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 131-141.
6. NINOMIYA JK, L'ITALIEN G, CRIQUI MH, WHYTE JL, GAMST A, CHEN RS: Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004; 109: 42-46.
7. LAKKA HM, LAAKSONEN DE, LAKKA TA, NISKANEN LK, KUMPUSALO E, TUOMILEHTO J, SALONEN JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
8. FESTA A, D'AGOSTINO R JR, HOWARD G, MYKKANEN L, TRACY RP, HAFFNER SM: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47.
9. KLEIN BE, KLEIN R, LEE KE: Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002; 25: 1790-1794.
10. DANDONA P, ALJADA A, MOHANTY P: The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 2002; 45: 924-930.
11. ROSAS M, PASTELIN G, MARTINEZ REDING J, HERRERA-ACOSTA J, ATTIE F: Comité Institucional para el Estudio y Prevención de la Hipertensión Arterial Sistémica. Hypertension guidelines in Mexico. Arch Cardiol Mex 2004; 74(2): 134-57.
12. International Diabetes Federation. The Consensus Worldwide Definition of the Metabolic Syndrome. Berlin, Alemania, April 2005. www.idf.org